Who invested in Tempest Therapeutics

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$4.5Mraised across 2 rounds since 2026, from 2 sources

$2.0MRound$2.5MRound

Latest round: Round, $2.5MSept 2026
Step-upi: 1.3×
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027

$2.0MRound$2.5MRound

First round: Round, $2.0M
Biggest round: $2.5M
Between rounds: 5 months

The rounds

Sept 2026
Round$2.5M5 new
Source recordedSEC filing: $4.1M sold
Apr 2026
Round$2.0M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $2.0M sold, first sale Apr 2026

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2026Round2026

New Enterprise Associates

Versant Ventures

Eight Roads Ventures

Foresite CapitalLilly Asia Ventures

Everyone who backed them

New Enterprise AssociatesVC firm1round

Versant VenturesVC firm1round

Eight Roads VenturesVC firm1round

Foresite CapitalPrivate equity1round

Lilly Asia VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tempest Therapeutics

Who invested in Tempest Therapeutics?

Tempest Therapeutics's investors include New Enterprise Associates, Versant Ventures, Eight Roads Ventures, Foresite Capital and Lilly Asia Ventures.

How much has Tempest Therapeutics raised?

Tempest Therapeutics has raised $4.5M across 2 rounds since 2026.

When did Tempest Therapeutics last raise?

Tempest Therapeutics's most recent round was an Undisclosed round of $2.5M in Sept 2026.

What was Tempest Therapeutics's biggest round?

Its most recent round, $2.5M in Sept 2026, is also its largest on record.

Who backed Tempest Therapeutics first?

Tempest Therapeutics's first round on record, in Sept 2026, was backed by New Enterprise Associates, Versant Ventures and Eight Roads Ventures and 2 others.